Moffitt Cancer Center researchers launched a first-of-its-kind study comparing the long-term benefits of radiation therapy in women with breast cancer either before surgery (neoadjuvant) or after surgery (adjuvant). Their study, published in the June 30 issue of Breast Cancer Research, found that patients who have neoadjuvant radiation therapy have a significantly lower risk of developing a second primary tumor at any site.

July 24, 2017 — TomTec Zero is the latest addition to the TomTec portfolio. Now every physician reading cardiovascular studies at locations such as the office, reading room or from home will have full diagnostic access to all images and clinical tools, including automated strain measurements.

When the Society of Cardiovascular Computed Tomography (SCCT) was formed in the mid-1990s, its primary goal was to have imagers, both cardiologists and radiologists, collaborate to improve cardiac CT image quality. In the past decade SCCT refocused efforts on gathering clinical trial evidence to show the efficacy and value of coronary CT angiography (CCTA) compared to the standard of care and other competing modalities.

Samsung announced U.S. Food and Drug Administration (FDA) approval of the BodyTom Elite, an upgraded version of its portable, full-body, 32-slice computed tomography (CT) scanner. The upgraded system features a new visual design, and upgraded software, hardware and workstation.

July 24, 2017 — The U.S. Food and Drug Administration’s (FDA) Center for Devices and Radiological Health (CDRH) has received approval from the Office of Management and Budget to extend all Radiation Safety reporting forms an additional three years until July 31, 2020.

El Camino Hospital (Mountain View, Calif.) announced the installation of a new Calypso 4-D Localization System and will soon be able to treat patients with certain soft tissue cancers using this precise radiation technology.

RaySearch Laboratories reported that eight additional proton therapy centers worldwide have recently chosen RayStation as their treatment planning system.

The U.S. Food and Drug Administration (FDA) has cleared the first magnetic resonance imaging (MRI) device specifically for neonatal brain and head imaging in neonatal intensive care units (NICU).

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now